# Institut de Recherche sur le Cancer et le Vieillissement de Nice

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/institut-de-recherche-sur-le-cancer-et-le-vieillissement-de-nice/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 29 |
| Citations | 260,495 |
| City | Nice |
| Country | FR |
| Description | Institut de Recherche sur le Cancer et le Vieillissement de Nice is a research organisation in Nice, FR. OpenAlex records 2,006 works and 260,495 citations for it. 412 researchers list it as their most recent affiliation. |
| Homepage | http://ircan.org/ |
| OpenAlex ID | https://openalex.org/I4210119200 |
| Region | Provence-Alpes-Côte d'Azur |
| Researchers | 412 |
| ROR ID | https://ror.org/01td3kv81 |
| Type | facility |
| Works | 2,006 |

## University papers

- [Prognostic factors in 1038 women with metastatic breast cancer](https://scholariq.org/papers/prognostic-factors-in-1038-women-with-metastatic-breast-cancer/)
- [MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines](https://scholariq.org/papers/mir-210-promotes-a-hypoxic-phenotype-and-increases-radioresistance-in-human-lung/)
- [Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome](https://scholariq.org/papers/expression-of-the-hypoxia-inducible-monocarboxylate-transporter-mct4-is/)
- [A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy](https://scholariq.org/papers/a-diagnostic-biopsy-adapted-immunoscore-predicts-response-to-neoadjuvant/)
- [Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer](https://scholariq.org/papers/late-toxicities-and-clinical-outcome-at-5-years-of-the-accord-12-0405-prodige-02/)
- [Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy](https://scholariq.org/papers/proton-beams-in-cancer-treatments-clinical-outcomes-and-dosimetric-comparisons/)
- [Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression](https://scholariq.org/papers/cytokine-expression-in-squamous-intraepithelial-lesions-of-the-uterine-cervix/)
- [Aromatase inhibition in male breast cancer patients: biological and clinical implications](https://scholariq.org/papers/aromatase-inhibition-in-male-breast-cancer-patients-biological-and-clinical/)
- [Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study](https://scholariq.org/papers/planned-organ-preservation-for-early-t2-3-rectal-adenocarcinoma-a-french/)
- [Circulating tumor cells in prostate cancer: A potential surrogate marker of survival](https://scholariq.org/papers/circulating-tumor-cells-in-prostate-cancer-a-potential-surrogate-marker-of/)
- [Can relaxation exercises improve students’ OSCE grades: a prospective study](https://scholariq.org/papers/can-relaxation-exercises-improve-students-osce-grades-a-prospective-study/)

## University researchers

- [J. Doyen](https://scholariq.org/researchers/j-doyen/)

## University top topics

Showing 8 of 25.

- [Telomeres, Telomerase, and Senescence](https://scholariq.org/topics/telomeres-telomerase-and-senescence/)
- [Fungal and yeast genetics research](https://scholariq.org/topics/fungal-and-yeast-genetics-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Mitochondrial Function and Pathology](https://scholariq.org/topics/mitochondrial-function-and-pathology/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.